Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Nucleoside drugs >  Deoxynucleotides and their analogs >  5-Methyl-2'-deoxycytidine

5-Methyl-2'-deoxycytidine

Basic information Safety Supplier Related

5-Methyl-2'-deoxycytidine Basic information

Product Name:
5-Methyl-2'-deoxycytidine
Synonyms:
  • 5-METHYL-DC
  • 5-METHYL-2'-DEXOYCYTIDINE
  • 4-AMINO-1-[(2R,4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-5-METHYL-PYRIMIDIN-2-ONE
  • 2’-deoxy-5-methyl-cytidin
  • 5-Me-2'-deoxycytidine
  • 2'-Deoxy-5-methylcytidine, ≥99%(HPLC)
  • 2'-Deoxy-5-Me-Cytidine
  • 5-methyldeoxycytidine
CAS:
838-07-3
MF:
C10H15N3O4
MW:
241.24
EINECS:
212-655-1
Product Categories:
  • Bases & Related Reagents
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Nucleotides
  • Pharmaceuticals
  • Biochemistry
  • Nucleosides and their analogs
  • Nucleosides, Nucleotides & Related Reagents
Mol File:
838-07-3.mol
More
Less

5-Methyl-2'-deoxycytidine Chemical Properties

Melting point:
217-219 °C(lit.)
Boiling point:
492.8±55.0 °C(Predicted)
Density 
1?+-.0.1 g/cm3(Predicted)
refractive index 
44 ° (C=1.4, H2O)
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
solubility 
DMSO (Slightly, Heated), Methanol (Slightly, Heated), Water (Slightly)
form 
Powder
pka
pK1:4.33 (25°C)
color 
White to Off-white
optical activity
41.1°(C=0.009986 g/ml H2O)
Water Solubility 
Soluble in water.
Stability:
Hygroscopic
InChI
InChI=1S/C10H15N3O4/c1-5-3-13(10(16)12-9(5)11)8-2-6(15)7(4-14)17-8/h3,6-8,14-15H,2,4H2,1H3,(H2,11,12,16)/t6-,7+,8+/m0/s1
InChIKey
LUCHPKXVUGJYGU-XLPZGREQSA-N
SMILES
OC[C@H]1O[C@@H](N2C=C(C)C(N)=NC2=O)C[C@@H]1O
CAS DataBase Reference
838-07-3(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-36-24/25
WGK Germany 
3
RTECS 
HA3860000
HS Code 
29389090

MSDS

More
Less

5-Methyl-2'-deoxycytidine Usage And Synthesis

Description

5-Methyl-2'-deoxycytidine is a nucleoside analogue that inhibits the synthesis of DNA. 5-Methyl-2'-deoxycytidine prevents methylation of guanine, which disrupts the binding of guanine nucleotide-binding proteins to the dna template and prevents polymerase chain reactions. 2'-Deoxy-5-methylcytidine is also a methyltransferase inhibitor, which means it blocks the enzyme responsible for adding methyl groups to cytosine molecules.

Chemical Properties

White Solid

Uses

5-Methyl-2'-deoxycytidine is a pyrimidine nucleoside that when incorporated into single-stranded DNA can act in cis to signal de novo DNA methylation. It has been used in epigenetics research to investigate the dynamics of DNA methylation pattern in the control of gene expression.

Uses

5-Methyl-2'-deoxycytidine in single-stranded DNA can act in cis to signal de novo DNA methylation.

Uses

A Cytidine (C998300) analog and also an isostere of Thymidine (T412000).

Definition

ChEBI: 5-methyl-2'-deoxycytidine is a 2'-deoxycytidine.

General Description

Giel-Pietraszuk et al. developed a new method for quantification of 5-methyl-2'-deoxycytidine (m5C) in the DNA. The technique is based on the conversion of m5C into fluorescent 3, N4-etheno-5-methyl-2'-deoxycytidine (εm5C) and its identification by reversed-phase high-performance liquid chromatography (RP-HPLC)[1].The measurement of 5-meC and 5-medC in urine may help assess changes in DNA methylation status in the whole body and investigate the DNA demethylation mechanism in vivo. 5-MedC was first detected in urine using an inhibition ELISA method;12 however, because ELISA may suffer from poor selectivity and sensitivity, later urinary measurements of 5-medC were developed mainly based on the chromatographic techniques[2].

Synthesis

50-89-5

838-07-3

The general procedure for the synthesis of 4-amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidin-2,4(1H,3H)-diones, using 1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one as a starting material was carried out as follows. DMF a nucleoside solution was prepared (substrate concentration of 0.3 M, except for compounds 3 and 4, which was 0.05 M) to which PyAOP (1.6 eq.) and DBU (1.6 eq.) were added. The reaction mixture was stirred at 20 °C for 1 min. Subsequently, N-nucleophilic reagent (4 eq. dissolved in THF if 1a was used, or concentrated NH4OH, 10 eq.) was added to the reaction system. The reaction continued to be stirred at 20 °C for 5 min to 4 h and the progress of the reaction was monitored by TLC. Upon completion of the reaction, the solution was concentrated under vacuum. Separation by fast column chromatography on silica gel afforded purified forms of the target product 5MedC and its oxidized derivatives 1'-20'.

References

[1] Ma?gorzata Giel-Pietraszuk. “Quantification of 5-methyl-2’-deoxycytidine in the DNA.” Acta biochimica Polonica 62 2 (2015): 281–6.
[2] Chiung-Wen Hu. “Direct Analysis of 5-Methylcytosine and 5-Methyl-2′-deoxycytidine in Human Urine by Isotope Dilution LC-MS/MS: Correlations with N-Methylated Purines and Oxidized DNA Lesions.” Chemical Research in Toxicology 25 2 (2012): 462–470.

5-Methyl-2'-deoxycytidineSupplier

Maanshan geneyan biotech Co.,LTD Gold
Tel
18913822354
Email
market@geneyan-bio.com
Nanjing Youwei Biotechnology Co., Ltd Gold
Tel
025-86506605 13952030024
Email
13811988123@139.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com